Bayforest Capital Ltd Increases Holdings in DaVita Inc. (NYSE:DVA)

Key Points

• Bayforest Capital Ltd increased its stake in DaVita Inc. by 331.1% during the first quarter, bringing its holdings to 3,259 shares valued at approximately $499,000.
• DaVita's stock received a buy rating upgrade from Wall Street Zen, with a current average target price of $167.40 despite some analysts maintaining a hold rating.
• In the most recent quarter, DaVita reported $2.00 EPS, exceeding analyst estimates by $0.25, and showed a 5.0% revenue increase compared to the same period last year.

Bayforest Capital Ltd increased its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 331.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,259 shares of the company's stock after buying an additional 2,503 shares during the quarter. Bayforest Capital Ltd's holdings in DaVita were worth $499,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Epoch Investment Partners Inc. bought a new stake in DaVita during the 4th quarter worth approximately $55,100,000. Invesco Ltd. lifted its position in shares of DaVita by 20.9% during the fourth quarter. Invesco Ltd. now owns 1,589,545 shares of the company's stock worth $237,716,000 after acquiring an additional 275,284 shares in the last quarter. Iron Triangle Partners LP purchased a new stake in shares of DaVita during the fourth quarter worth $38,946,000. GAMMA Investing LLC raised its position in shares of DaVita by 14,695.8% in the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after buying an additional 233,222 shares in the last quarter. Finally, Bridgewater Associates LP raised its position in shares of DaVita by 298.4% in the fourth quarter. Bridgewater Associates LP now owns 239,970 shares of the company's stock worth $35,888,000 after buying an additional 179,744 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DVA. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Truist Financial reduced their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $167.40.

DaVita Stock Down 1.4%

DaVita stock traded down $1.93 during trading hours on Friday, hitting $138.44. 686,266 shares of the stock traded hands, compared to its average volume of 672,836. The firm's 50-day moving average price is $140.44 and its two-hundred day moving average price is $147.92. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. The company has a market cap of $10.45 billion, a PE ratio of 13.72, a PEG ratio of 0.97 and a beta of 1.09. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the firm posted $2.26 EPS. The business's revenue for the quarter was up 5.0% compared to the same quarter last year. On average, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.